3x Reta (40MG) (120MG Total)
54 in stock
Retatrutide (LY-3437943) – 3 × 40 MG
Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) developed as a next-generation incretin analog. Its broad activation profile supports studies in glucose regulation, weight management, and metabolic health. This bulk 3-pack provides three vials for extended laboratory use.
Note: Not for human or veterinary use. For in-vitro research only.
Retatrutide (LY-3437943) – 3 × 40 MG
Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) developed as a next-generation incretin analog. Its broad activation profile supports studies in glucose regulation, weight management, and metabolic health. This bulk 3-pack provides three vials for extended laboratory use.
Note: Not for human or veterinary use. For in-vitro research only.
Regulatory & Use
For laboratory research only. Not for human or veterinary use.